Mesa Laboratories - MLAB Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $130.00
  • Forecasted Upside: 29.05%
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$100.74
▲ +1.12 (1.12%)

This chart shows the closing price for MLAB by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Mesa Laboratories Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for MLAB and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for MLAB

Analyst Price Target is $130.00
▲ +29.05% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Mesa Laboratories in the last 3 months. The average price target is $130.00, with a high forecast of $130.00 and a low forecast of $130.00. The average price target represents a 29.05% upside from the last price of $100.74.

This chart shows the closing price for MLAB for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Buy

The current consensus among 1 contributing investment analysts is to buy stock in Mesa Laboratories. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/28/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/26/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/26/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/25/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/23/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/21/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/21/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/20/2024

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/4/2024Evercore ISIBoost TargetOutperform ➝ Outperform$124.00 ➝ $130.00Low
1/4/2024Evercore ISIUpgradeIn-Line ➝ Outperform$100.00 ➝ $125.00Low
11/15/2022Evercore ISIBoost Target$166.00Low
11/9/2020KeyCorpInitiated CoverageSector Weight ➝ Sector Weight$287.00High
10/2/2020JPMorgan Chase & Co.Initiated CoverageNeutral$260.00Low
12/4/2019Jefferies Financial GroupInitiated CoverageBuy$275.00 ➝ $275.00High
8/26/2019Evercore ISIInitiated CoverageOutperform$250.00High
(Data available from 4/21/2019 forward)

News Sentiment Rating

0.65 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 3 very positive mentions
  • 0 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
9/23/2023
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/23/2023
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/22/2023
  • 1 very positive mentions
  • 0 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
12/22/2023
  • 3 very positive mentions
  • 6 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
1/21/2024
  • 3 very positive mentions
  • 8 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
2/20/2024
  • 3 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/21/2024
  • 4 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/20/2024

Current Sentiment

  • 4 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mesa Laboratories logo
Mesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. It operates in four segments: Clinical Genomics, Sterilization and Disinfection Control, Biopharmaceutical Development, and Calibration Solutions. The Clinical Genomics segment develops, manufactures, and sells genetic analysis tools that include MassARRAY system and consumables, including chips, panels, and chemical reagent solutions used by clinical labs to perform genomic clinical testing in various therapeutic areas, such as screenings for hereditary diseases, pharmacogenetics, and oncology related applications. The Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries. This segment also provides testing and laboratory services primarily to the dental industry. The Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis and peptide synthesis solutions. This segment's solutions include protein analysis comprising analysis equipment, CDs, kits, and buffers; and peptide synthesizers that enable customers to automate chemical synthesis of peptides that are used in the creation of peptide therapies, biomaterials, cosmetics, and general research. The Calibration Solutions segment designs, manufactures, and markets quality control products to measure or calibrate temperature, pressure, pH, and humidity for health and safety purposes in the hospital, medical device manufacturing, pharmaceutical manufacturing, and various laboratory environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.
Read More

Today's Range

Now: $100.74
Low: $98.91
High: $101.95

50 Day Range

MA: $104.47
Low: $90.86
High: $114.10

52 Week Range

Now: $100.74
Low: $82.86
High: $178.64

Volume

27,080 shs

Average Volume

36,161 shs

Market Capitalization

$542.99 million

P/E Ratio

592.62

Dividend Yield

0.64%

Beta

0.83

Frequently Asked Questions

What sell-side analysts currently cover shares of Mesa Laboratories?

The following sell-side analysts have issued research reports on Mesa Laboratories in the last twelve months: Evercore ISI, and StockNews.com.
View the latest analyst ratings for MLAB.

What is the current price target for Mesa Laboratories?

1 Wall Street analysts have set twelve-month price targets for Mesa Laboratories in the last year. Their average twelve-month price target is $130.00, suggesting a possible upside of 29.0%. Evercore ISI has the highest price target set, predicting MLAB will reach $130.00 in the next twelve months. Evercore ISI has the lowest price target set, forecasting a price of $130.00 for Mesa Laboratories in the next year.
View the latest price targets for MLAB.

What is the current consensus analyst rating for Mesa Laboratories?

Mesa Laboratories currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe MLAB will outperform the market and that investors should add to their positions of Mesa Laboratories.
View the latest ratings for MLAB.

What other companies compete with Mesa Laboratories?

Other companies that are similar to Mesa Laboratories include Senseonics, Valneva, InnovAge, Novavax and Applied Therapeutics. Learn More about companies similar to Mesa Laboratories.

How do I contact Mesa Laboratories' investor relations team?

Mesa Laboratories' physical mailing address is 12100 W 6TH AVE, LAKEWOOD CO, 80228. The medical instruments supplier's listed phone number is (303) 987-8000 and its investor relations email address is [email protected]. The official website for Mesa Laboratories is www.mesalabs.com. Learn More about contacing Mesa Laboratories investor relations.